This topic contains a solution. Click here to go to the answer

Author Question: Palliative care measures dictate that the room of a dying patient should be A) kept dimly ... (Read 79 times)

cabate

  • Hero Member
  • *****
  • Posts: 537
Palliative care measures dictate that the room of a dying patient should be
 
  A)
 
  kept dimly lit.
  B)
 
  kept dark.
  C)
 
  made unusually bright.
  D)
 
  adjusted to suit the patient.

Question 2

Medical and surgical care is included in rehabilitation services.
 
  True
 
  False



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nicoleclaire22

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

Answer:

D

Answer to Question 2

True




cabate

  • Member
  • Posts: 537
Reply 2 on: Jul 16, 2018
Excellent


samiel-sayed

  • Member
  • Posts: 337
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library